04/25/2024
11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
3:33 PM | Applied Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
3:37 PM | Applied Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:38 PM | Applied Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:39 PM | Applied Therapeutics (Filer)
| Form ARS | |
04/15/2024
4:27 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
4:30 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/15/2024
4:00 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:41 PM | Applied Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:31 PM | Applied Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
4:57 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:00 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:02 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:12 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:49 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2024
4:51 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:42 PM | Applied Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2024
7:17 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
2:17 PM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
03/06/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:12 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:42 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
02/29/2024
3:18 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
1:26 PM | Applied Therapeutics (Subject)
Propel Bio Management, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:20 PM | Applied Therapeutics (Subject)
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
5:30 PM | Applied Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
3:22 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
1:40 PM | Applied Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
12:50 PM | Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Applied Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
7:49 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
01/03/2024
8:15 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:23 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
11:29 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
12/06/2023
3:15 PM | Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
12/05/2023
6:03 PM | Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:42 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
AI finds its first serious application (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
12/01/2023
6:42 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:42 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
5:53 PM | Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:41 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:10 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
11/09/2023
6:47 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
6:36 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:37 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:44 PM | Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:33 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:42 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023
3:42 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2023
6:17 PM | Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
3:42 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
7:02 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
7:02 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
7:03 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
7:08 PM | Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:12 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:50 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:40 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:40 PM | Applied Therapeutics (Issuer)
Thorpe Catherine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/16/2023
3:40 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
8:01 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:02 PM | Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:02 PM | Applied Therapeutics (Issuer)
Lerner Teena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:03 PM | Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:03 PM | Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2023
11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |
05/11/2023
6:51 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:13 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
11:03 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
05/02/2023
12:24 PM | Applied Therapeutics (Subject)
Propel Bio Management, LLC (Filed by)
| Form SC 13G | |
